Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 147

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 147
---
 with entering into the Divestiture Agreement, on December 19, 2024, following the approval thereof by Aadi’s board of directors, Kaken and Aadi entered into the Support Agreements with each of the directors and executive officers of Aadi, certain of their affiliates, and one other significant stockholder of Aadi, who collectively beneficially own or control an aggregate of approximately [●]% of the outstanding shares of Aadi’s common stock (the “Support Agreement Stockholders”) as of the Record Date. Under the Support Agreements, the Support Agreement Stockholders have agreed to vote all of their shares of our common stock:

| • |     | in favor of (1) the Divestiture Proposal and the other transactions contemplated by the Divestiture                                                                                                                                                  
 Agreement (to the extent proposed to be voted upon or consented to by the Aadi stockholders) and the approval of the Divestiture Agreement that does not change the form of the consideration payable to Aadi upon the closing under the Divestiture 
 Agreement or reduce the consideration thereunder, (2) certain specified transactions as listed on a schedule to the Divestiture Agreement and (3) the Adjournment Proposal; and                                                                      |

| • |     | against (1) any action or agreement in favor of an acquisition proposal (including a Superior Proposal),                                                                                                                                          
 without regard to the terms of such acquisition proposal, or any of the transactions contemplated thereby, (2) any action or proposal that would reasonably be expected to result in a breach of any covenant, representation or warranty, or any 
 other obligation or agreement of Aadi or Aadi Sub under the Divestiture Agreement or of a Support Agreement Stockholder under the Support Agreement and (3) any action, proposal, transaction or agreement that would reasonably be expected to   
 impede, interfere with, delay, discourage, adversely affect or inhibit the timely consummation of the Divestiture or the fulfillment of Kaken’s, Aadi’s or Aadi Sub conditions to closing under the Divestiture Agreement or change in any        
 manner the voting rights of the shares of our common stock or any other shares of capital stock of Aadi (including, without limitation, any extraordinary corporate transaction, such as a merger, consolidation, amalgamation, plan or scheme of 
 arrangement, share exchange, business combination, division, conversion, transfer, domestication, continuance or similar transaction, any amendments of Aadi’s organizational or governing documents, or any sale, lease, sublease, exchange